Skip to main content
< Back to news
 07.07.2017

Present your innovative project at the Asebio Investor Day!

The Spanish Bioindustry Association (ASEBIO) and the Spanish Biotech Platform organize the Asebio Investor Day, in collaboration with PCB and Biocat and with the support of ICEX-Invest in Spain. The event will be held on 26 and 27 September at PCB and it is composed of two parts: An investor forum, with leading investors and pharmaceutical companies from around the world on 27 September, and a seminar given by Johnson & Johnson Innovation JLABS on 26 Setember. 

 

The Advisory Committee will evaluate and select the best projects among all applications received, with the goal of inviting those projects and companies of the highest quality. From the requests received, 30 companies or projects will be selected to give their pitch at the forum and hold partnering meetings.

The event will feature a variety of investors from Spain and abroad, interested to identify investment and licensing opportunities in Spain including: Business Angels Network of Catalonia (BANC), Bifröst Health, Biogeneration Ventures, BioSeed Capital, Caixa Capital Risc, el Centro para el Desarrollo Tecnológico Industrial (CDTI), Checkpoint Partners, Columbus Venture Partners, CRB Inverbío, DCN Ventures, Edmond de Rothschild Investment Partners, Genesis Biomed, Healthequity S.C.R, InKemia Knowledge Capital Fund, Inveready Technology Investment Group, Johnson & Johnson Innovatio -JLABS, Kurma Partners, Laboratorios Rubio-Products & Technology, Merck Ventures, Merck, Sharp & Dohme, Novartis Venture Fund, Omnix Health, Uninvest, Ventac Partners i Ysios Capital. More information about investors: http://www.investorday.eu/investors.html

Johnson & Johnson Innovation Training Day

Innovative biotech companies interested in better communicating their business plan to investors, as well as improving basic aspects of business development, may participate for free in the Johnson & Johnson Innovation Training Day.

During the workshop, Lilian Alcaraz New Ventures and Transaction Lead for Neuroscience at Johnson & Johnson Innovation will share  the tricks of the trade in preparing a non-confidential deck and executive summary, and Rick Davis,  Senior Director of New Ventures and Transactions for Oncology will explain to participants the key business development skills to help successfully evaluate and manage strategic alliances and other potential growth opportunities.